Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours

A. Chiti, V. Briganti, S. Fanti, N. Monetti, R. Masi, E. Bombardieri

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background. Somatostatin receptor imaging with 111In-pentetreotide is widely accepted as an essential step in the management of patients affected by neuroendocrine tumours of the gastro-entero-pancreatic tract. Many data are already available on the high sensitivity of this technique. Methods. We present a review of the published data together with the results of a study involving 253 patients submitted to somatostatin receptor imaging in three Italian hospitals. The patients were divided into two groups treated with different acquisition and processing protocols. Results. The overall sensitivity was as high as (169/176) 96% in both groups, while the specificity was higher in the group in which semi-quantitative evaluation of somatostatin receptor density was performed: (23/26) 88% vs (39/51) 76%. The use of this method is recommended to increase the specificity of 111In-pentetreotide imaging. Conclusions. Our results with somatostatin receptor imaging in neuroendocrine tumours of the gastro-entero-pancreatic tract demonstrate that all figures of merit are excellent when imaging is accurately performed and analysed by experienced operators.

Original languageEnglish
Pages (from-to)42-49
Number of pages8
JournalQuarterly Journal of Nuclear Medicine
Volume44
Issue number1
Publication statusPublished - 2000

Fingerprint

Somatostatin Receptors
Neuroendocrine Tumors
Neoplasms
pentetreotide

Keywords

  • Indium radioisotopes
  • Gastrointestinal neoplasms
  • Neuroendocrine tumours
  • Receptors somatostatin analysis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Chiti, A., Briganti, V., Fanti, S., Monetti, N., Masi, R., & Bombardieri, E. (2000). Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours. Quarterly Journal of Nuclear Medicine, 44(1), 42-49.

Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours. / Chiti, A.; Briganti, V.; Fanti, S.; Monetti, N.; Masi, R.; Bombardieri, E.

In: Quarterly Journal of Nuclear Medicine, Vol. 44, No. 1, 2000, p. 42-49.

Research output: Contribution to journalArticle

Chiti, A, Briganti, V, Fanti, S, Monetti, N, Masi, R & Bombardieri, E 2000, 'Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours', Quarterly Journal of Nuclear Medicine, vol. 44, no. 1, pp. 42-49.
Chiti, A. ; Briganti, V. ; Fanti, S. ; Monetti, N. ; Masi, R. ; Bombardieri, E. / Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours. In: Quarterly Journal of Nuclear Medicine. 2000 ; Vol. 44, No. 1. pp. 42-49.
@article{23c1a069eaa640609625734823e6cd70,
title = "Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours",
abstract = "Background. Somatostatin receptor imaging with 111In-pentetreotide is widely accepted as an essential step in the management of patients affected by neuroendocrine tumours of the gastro-entero-pancreatic tract. Many data are already available on the high sensitivity of this technique. Methods. We present a review of the published data together with the results of a study involving 253 patients submitted to somatostatin receptor imaging in three Italian hospitals. The patients were divided into two groups treated with different acquisition and processing protocols. Results. The overall sensitivity was as high as (169/176) 96{\%} in both groups, while the specificity was higher in the group in which semi-quantitative evaluation of somatostatin receptor density was performed: (23/26) 88{\%} vs (39/51) 76{\%}. The use of this method is recommended to increase the specificity of 111In-pentetreotide imaging. Conclusions. Our results with somatostatin receptor imaging in neuroendocrine tumours of the gastro-entero-pancreatic tract demonstrate that all figures of merit are excellent when imaging is accurately performed and analysed by experienced operators.",
keywords = "Indium radioisotopes, Gastrointestinal neoplasms, Neuroendocrine tumours, Receptors somatostatin analysis",
author = "A. Chiti and V. Briganti and S. Fanti and N. Monetti and R. Masi and E. Bombardieri",
year = "2000",
language = "English",
volume = "44",
pages = "42--49",
journal = "Journal of Nuclear Medicine and Allied Sciences",
issn = "1124-3937",
publisher = "Minerva Medica",
number = "1",

}

TY - JOUR

T1 - Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours

AU - Chiti, A.

AU - Briganti, V.

AU - Fanti, S.

AU - Monetti, N.

AU - Masi, R.

AU - Bombardieri, E.

PY - 2000

Y1 - 2000

N2 - Background. Somatostatin receptor imaging with 111In-pentetreotide is widely accepted as an essential step in the management of patients affected by neuroendocrine tumours of the gastro-entero-pancreatic tract. Many data are already available on the high sensitivity of this technique. Methods. We present a review of the published data together with the results of a study involving 253 patients submitted to somatostatin receptor imaging in three Italian hospitals. The patients were divided into two groups treated with different acquisition and processing protocols. Results. The overall sensitivity was as high as (169/176) 96% in both groups, while the specificity was higher in the group in which semi-quantitative evaluation of somatostatin receptor density was performed: (23/26) 88% vs (39/51) 76%. The use of this method is recommended to increase the specificity of 111In-pentetreotide imaging. Conclusions. Our results with somatostatin receptor imaging in neuroendocrine tumours of the gastro-entero-pancreatic tract demonstrate that all figures of merit are excellent when imaging is accurately performed and analysed by experienced operators.

AB - Background. Somatostatin receptor imaging with 111In-pentetreotide is widely accepted as an essential step in the management of patients affected by neuroendocrine tumours of the gastro-entero-pancreatic tract. Many data are already available on the high sensitivity of this technique. Methods. We present a review of the published data together with the results of a study involving 253 patients submitted to somatostatin receptor imaging in three Italian hospitals. The patients were divided into two groups treated with different acquisition and processing protocols. Results. The overall sensitivity was as high as (169/176) 96% in both groups, while the specificity was higher in the group in which semi-quantitative evaluation of somatostatin receptor density was performed: (23/26) 88% vs (39/51) 76%. The use of this method is recommended to increase the specificity of 111In-pentetreotide imaging. Conclusions. Our results with somatostatin receptor imaging in neuroendocrine tumours of the gastro-entero-pancreatic tract demonstrate that all figures of merit are excellent when imaging is accurately performed and analysed by experienced operators.

KW - Indium radioisotopes

KW - Gastrointestinal neoplasms

KW - Neuroendocrine tumours

KW - Receptors somatostatin analysis

UR - http://www.scopus.com/inward/record.url?scp=0034115734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034115734&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 42

EP - 49

JO - Journal of Nuclear Medicine and Allied Sciences

JF - Journal of Nuclear Medicine and Allied Sciences

SN - 1124-3937

IS - 1

ER -